ArticleScientific reports2026
Genomic and structural elucidation of multi-heavy metal tolerance in the p-nitrophenol-degrading bacterium Pseudomonas asiatica strain PNPG3.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomonas asiatica strain PNPG3 demonstrated broad-spectrum heavy-metal tolerance, with minimum inhibitory concentrations (MICs) of 800, 400, 4, and 6 µg/mL (ppm) for arsenite, cadmium (Cd), cobalt (Co), and nickel (Ni), respectively. When exposed to 1 mM arsenite, strain PNPG3 retained approximately 89% of its p-nitrophenol (PNP) degradation efficiency relative to the PNP-only baseline, mineralizing 86% of 0.5 mM PNP within 66 h and releasing 0.41 mM nitrite, indicating strong catabolic resilience under combined PNP–arsenite stress. Genome analysis identified a distinct arsenic (As) tolerance and biotransformation gene cluster on contig 1, comprising coordinated transport, regulatory, and metabolic components, including an ArsR/SmtB family transcriptional regulator and an ArsJ-associated glyceraldehyde-3-phosphate dehydrogenase, suggesting the presence of a specialized and potentially novel As detoxification mechanism. Comparative genomics further revealed conservation of key abiotic and biotic stress response genes, along with metabolic pathways supporting degradation of styrene, dioxins, polycyclic aromatic hydrocarbons, cyanate, and diverse aromatic xenobiotics. Chromate reductase (ChrR) and arsenate reductase (ArsC), key enzymes involved in the biotransformation of Cr (VI) to Cr (III) and arsenate [As(V)] to arsenite [As(III)], respectively, were modeled, characterized, and validated, followed by docking analyses to elucidate heavy-metal interactions at their active sites. Molecular dynamics simulation (MDS) indicated that the ArsC–arsenate complex exhibited higher structural stability and compactness, with limited conformational fluctuations, implied greater robustness of arsenate reduction compared to Cr(VI) reduction under in situ metal stress conditions. Overall, the phenotypic robustness and genomic potential of strain PNPG3 underscore its strong capacity for heavy-metal tolerance, PNP biodegradation, and arsenate biotransformation, highlighting its promise for scalable bioremediation applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.